MedAvail Holdings, Inc. (MDVLQ) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist MedAvail Holdings, Inc. (MDVLQ) ein Healthcare-Unternehmen mit einer Bewertung von 0. Die Aktie erzielt 50/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 16. März 2026MedAvail Holdings, Inc. (MDVLQ) Gesundheitswesen & Pipeline-Uebersicht
MedAvail Holdings, Inc. was a technology-driven retail pharmacy company offering self-service kiosk solutions and mobile applications in the United States and Canada. Focused on onsite prescription dispensing via its MedAvail MedCenter, the company connected patients with pharmacists remotely. MedAvail filed for Chapter 7 liquidation in early 2024.
Investmentthese
MedAvail Holdings, Inc. presented an investment case centered on its innovative approach to pharmacy services through technology. The company's self-service kiosks and remote pharmacist model aimed to improve convenience and access to medications. However, with a negative profit margin of -106.2%, a negative ROE of -194.7%, and a debt-to-equity ratio of 9.82, the company's financial health was a significant concern. The company's beta of -134.43 suggests an inverse correlation with the market, but this is less relevant given its bankruptcy filing. The Chapter 7 liquidation filing on February 2, 2024, represents a critical event, rendering the stock essentially worthless.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.00B, reflecting the company's distressed financial state and Chapter 7 liquidation.
- Profit margin of -106.2%, indicating significant losses relative to revenue.
- Gross margin of 5.2%, suggesting limited profitability even before considering operating expenses.
- Return on Equity (ROE) of -194.7%, highlighting the company's inability to generate profits from shareholder equity.
- Debt-to-Equity ratio of 9.82, signaling a high level of financial leverage.
Wettbewerber & Vergleichsunternehmen
Staerken
- Innovative self-service pharmacy kiosk technology.
- Remote pharmacist consultation capabilities.
- Potential for improved medication access and adherence.
- Strategic partnerships with medical clinics and retail locations.
Schwaechen
- High capital expenditure for kiosk deployment.
- Regulatory hurdles and licensing requirements.
- Limited brand recognition and market share.
- Dependence on partnerships for kiosk placement.
Katalysatoren
- Ongoing: Bankruptcy proceedings and asset liquidation.
Risiken
- Ongoing: Complete loss of investment due to liquidation.
- Potential: Legal challenges or claims arising from the bankruptcy proceedings.
- Potential: Delisting from the OTC market.
Wachstumschancen
- Expansion of MedAvail MedCenters into Underserved Areas: MedAvail could have explored expanding its MedCenter kiosks into rural or underserved areas where access to traditional pharmacies is limited. This could have been achieved through partnerships with community health centers or mobile healthcare providers. The market size for rural healthcare is substantial, with ongoing efforts to improve access through telehealth and remote services. Timeline: 2-3 years for significant expansion.
- Integration with Telehealth Platforms: Integrating MedAvail's services with existing telehealth platforms could have provided a seamless experience for patients seeking remote consultations and prescription fulfillment. This would have required developing APIs and partnerships with telehealth providers. The telehealth market is projected to reach $55 billion by 2027, presenting a significant opportunity. Timeline: 1-2 years for initial integration.
- Partnerships with Employer-Sponsored Health Clinics: Collaborating with employers to install MedAvail MedCenters in on-site health clinics could have provided employees with convenient access to medications and pharmacist consultations. This would have required targeting large employers with a focus on employee wellness programs. The employer-sponsored health market is growing, driven by efforts to reduce healthcare costs and improve employee health. Timeline: 1-2 years for pilot programs.
- Development of a Mobile Pharmacy App: Creating a mobile app that allows patients to manage prescriptions, consult with pharmacists, and locate MedAvail MedCenters could have enhanced the company's digital presence and improved patient engagement. This would have required investing in app development and marketing. The mobile health market is expanding rapidly, with increasing adoption of digital health solutions. Timeline: 6-12 months for initial app launch.
- Expansion into Canada: Expanding its kiosk network into Canada could have provided access to a new market. This would have required navigating Canadian healthcare regulations and establishing partnerships with Canadian healthcare providers. The Canadian pharmacy retail market is substantial, with a growing demand for convenient and accessible pharmacy services. Timeline: 2-3 years for initial expansion.
Chancen
- Expansion into underserved areas with limited pharmacy access.
- Integration with telehealth platforms and remote patient monitoring systems.
- Partnerships with employer-sponsored health clinics.
- Development of a mobile pharmacy app for enhanced patient engagement.
Risiken
- Competition from established pharmacy chains and online pharmacies.
- Changes in healthcare regulations and reimbursement policies.
- Technological obsolescence and the emergence of new pharmacy solutions.
- Cybersecurity risks and data privacy concerns.
Wettbewerbsvorteile
- Proprietary MedAvail MedCenter technology.
- Established network of partnerships with medical clinics, retail stores, and employer sites.
- First-mover advantage in the self-service pharmacy kiosk market.
- Integration of remote pharmacist consultations with on-site dispensing.
Ueber MDVLQ
MedAvail Holdings, Inc. was established as a technology-enabled retail pharmacy company focused on developing and commercializing innovative self-service pharmacy solutions. The company's core offering was the MedAvail MedCenter, a self-service kiosk designed for deployment in medical clinics, retail locations, employer sites, and other convenient locations. These kiosks provided patients with on-site access to prescription medications, facilitated by a live audiovisual connection to a remote pharmacist. This allowed for real-time supervision and counseling during the dispensing process. MedAvail aimed to improve medication access and adherence by offering a convenient and efficient alternative to traditional pharmacies. The company's solutions were available in the United States and Canada. However, on February 2, 2024, MedAvail Holdings, Inc. and its affiliates filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware, marking the end of its operations.
Was das Unternehmen tut
- Developed and commercialized self-service pharmacy kiosks (MedAvail MedCenters).
- Offered on-site prescription dispensing in various locations.
- Established audiovisual connections to live pharmacists for remote consultations.
- Provided a mobile application for managing prescriptions.
- Aimed to improve medication access and adherence.
- Served patients in the United States and Canada.
Geschaeftsmodell
- Generated revenue through the dispensing of prescription medications via its MedAvail MedCenters.
- Charged fees for pharmacist consultations and related services.
- Established partnerships with medical clinics, retail stores, and employer sites to host MedAvail MedCenters.
- Focused on improving medication access and adherence for patients.
Branchenkontext
MedAvail Holdings, Inc. operated within the pharmaceutical retail industry, which is characterized by increasing demand for convenient and accessible healthcare services. The industry is dominated by large pharmacy chains and faces competition from online pharmacies and mail-order services. MedAvail attempted to carve out a niche by offering self-service kiosks and remote pharmacist consultations. However, the company's bankruptcy filing indicates the challenges of competing in this landscape, particularly with a capital-intensive business model and the need to establish partnerships with healthcare providers and retail locations.
Wichtige Kunden
- Patients seeking convenient access to prescription medications.
- Medical clinics and healthcare providers looking to offer on-site pharmacy services.
- Retail stores and employer sites seeking to enhance customer and employee benefits.
- Individuals in the United States and Canada.
Finanzdaten
Chart & Info
MedAvail Holdings, Inc. (MDVLQ) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer MDVLQ verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer MDVLQ.
Kursziele
Wall-Street-Kurszielanalyse fuer MDVLQ.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von MDVLQ auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Wettbewerber & Vergleichsunternehmen
MDVLQ OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that MedAvail Holdings, Inc. did not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may be distressed, bankrupt, or unwilling to provide audited financial statements. Trading on the OTC Other tier carries significant risks due to the lack of regulatory oversight and transparency compared to exchanges like the NYSE or NASDAQ.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure and transparency.
- High risk of fraud and manipulation.
- Potential for delisting and loss of investment.
- Significant price volatility and illiquidity.
- Bankruptcy and liquidation risk.
- Verify the company's legal status and registration.
- Review any available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Be aware of the potential for fraud and manipulation.
- Presence of a functional website (if available).
- Any available news coverage or press releases (if any).
- Information on the company's management team (if available).
- Verification of the company's registration with regulatory authorities (if possible).
Haeufige Fragen zu MDVLQ
What are the key factors to evaluate for MDVLQ?
MedAvail Holdings, Inc. (MDVLQ) currently holds an AI score of 50/100, indicating moderate score. Key strength: Innovative self-service pharmacy kiosk technology.. Primary risk to monitor: Ongoing: Complete loss of investment due to liquidation.. This is not financial advice.
How frequently does MDVLQ data refresh on this page?
MDVLQ prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven MDVLQ's recent stock price performance?
Recent price movement in MedAvail Holdings, Inc. (MDVLQ) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Innovative self-service pharmacy kiosk technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider MDVLQ overvalued or undervalued right now?
Determining whether MedAvail Holdings, Inc. (MDVLQ) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying MDVLQ?
Before investing in MedAvail Holdings, Inc. (MDVLQ), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding MDVLQ to a portfolio?
Potential reasons to consider MedAvail Holdings, Inc. (MDVLQ) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Innovative self-service pharmacy kiosk technology.. Additionally: Remote pharmacist consultation capabilities.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of MDVLQ?
Yes, most major brokerages offer fractional shares of MedAvail Holdings, Inc. (MDVLQ) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MDVLQ's earnings and financial reports?
MedAvail Holdings, Inc. (MDVLQ) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for MDVLQ earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is based on publicly available data and news reports.
- The company has filed for Chapter 7 liquidation, which significantly impacts its financial viability and stock value.